PerkinElmer Sues Intema over Down Syndrome Test IP | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer last week filed a suit against UK-based Intema seeking to invalidate that firm's US patent covering a Down syndrome test.

The suit, which was filed in the US District Court for the District of Massachusetts, seeks a declaration from the court that one or more of the claims of US Patent No. 6,573,103 are invalid. The patent is entitled, "Antenatal Screening for Down's Syndrome," and was issued in June 2003.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.